BR112015031820A2 - composto, composição farmacêutica, intermediário, processo para a preparação de um composto e métodos - Google Patents

composto, composição farmacêutica, intermediário, processo para a preparação de um composto e métodos

Info

Publication number
BR112015031820A2
BR112015031820A2 BR112015031820A BR112015031820A BR112015031820A2 BR 112015031820 A2 BR112015031820 A2 BR 112015031820A2 BR 112015031820 A BR112015031820 A BR 112015031820A BR 112015031820 A BR112015031820 A BR 112015031820A BR 112015031820 A2 BR112015031820 A2 BR 112015031820A2
Authority
BR
Brazil
Prior art keywords
compound
methods
pharmaceutical composition
preparing
preparation
Prior art date
Application number
BR112015031820A
Other languages
English (en)
Inventor
Posteraro Brunella
DEODATO Davide
DE LUCA Filomena
Maccari Giorgio
Docquier Jean-Denis
Botta Maurizio
SANGUINETTI Maurizio
Sanfilippo Stefania
Original Assignee
Cygnet Biosciences B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cygnet Biosciences B V filed Critical Cygnet Biosciences B V
Publication of BR112015031820A2 publication Critical patent/BR112015031820A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4192—1,2,3-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/20—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/24—Y being a hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

composto, composição farmacêutica, intermediário, processo para a preparação de um composto e métodos the present invention relates to macrocyclic amidinourea derivatives, methods of preparation and uses thereof, pharmaceutical compositions in particular to be used as chitinase inhibitors.
BR112015031820A 2013-06-18 2014-06-18 composto, composição farmacêutica, intermediário, processo para a preparação de um composto e métodos BR112015031820A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361836401P 2013-06-18 2013-06-18
PCT/EP2014/062896 WO2014202697A1 (en) 2013-06-18 2014-06-18 New macrocyclic amidinourea derivatives, methods of preparation and uses thereof as chitinase inhibitors

Publications (1)

Publication Number Publication Date
BR112015031820A2 true BR112015031820A2 (pt) 2017-07-25

Family

ID=50979767

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015031820A BR112015031820A2 (pt) 2013-06-18 2014-06-18 composto, composição farmacêutica, intermediário, processo para a preparação de um composto e métodos

Country Status (10)

Country Link
US (1) US10071975B2 (pt)
EP (1) EP3010896B1 (pt)
JP (1) JP6586416B2 (pt)
CN (1) CN105612147B (pt)
AU (1) AU2014283281C1 (pt)
BR (1) BR112015031820A2 (pt)
CA (1) CA2915767A1 (pt)
MX (1) MX363622B (pt)
PT (1) PT3010896T (pt)
WO (1) WO2014202697A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9135200B2 (en) 2013-06-28 2015-09-15 Futurewei Technologies, Inc. System and method for extended peripheral component interconnect express fabrics
EP3854789A1 (en) 2020-01-22 2021-07-28 Cygnet Biosciences B.V. Macrocyclic compounds useful as chitinase inhibitors
CN113773233B (zh) * 2021-09-18 2022-05-06 中国农业大学 一种甲基胍基脲衍生物及其制备方法与应用
CN115754090B (zh) * 2022-12-15 2023-08-29 华夏生生药业(北京)有限公司 一种lc-ms检测氟康唑相关杂质的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1114155A (en) * 1964-08-24 1968-05-15 Evans Medical Ltd Guanidino derivatives
WO2009113033A2 (en) * 2008-03-13 2009-09-17 Università Degli Studi Di Siena Linear and cyclic guanidine derivatives, method of preparation and uses thereof

Also Published As

Publication number Publication date
CA2915767A1 (en) 2014-12-24
EP3010896B1 (en) 2017-11-01
PT3010896T (pt) 2018-03-07
JP6586416B2 (ja) 2019-10-02
AU2014283281A1 (en) 2016-02-04
JP2016522236A (ja) 2016-07-28
MX363622B (es) 2019-03-28
AU2014283281B2 (en) 2018-10-04
AU2014283281C1 (en) 2019-01-24
CN105612147A (zh) 2016-05-25
MX2015017446A (es) 2016-08-12
US20160137617A1 (en) 2016-05-19
EP3010896A1 (en) 2016-04-27
US10071975B2 (en) 2018-09-11
CN105612147B (zh) 2018-06-05
WO2014202697A1 (en) 2014-12-24

Similar Documents

Publication Publication Date Title
CL2016000882A1 (es) Composiciones de arni contra el componente c5 del complemento y métodos para su uso (divisional de sol. n°2710-15).
CR20140275A (es) Triazolopiridinas sustituidas
UA113651C2 (xx) Макроциклічні пурини для лікування вірусних інфекцій
UA118666C2 (uk) Похідні піразолу
EA201591728A1 (ru) Гетероциклические соединения и способы их применения
EA201590887A1 (ru) Композиция
EA201500801A1 (ru) Бензохинолоновые ингибиторы vmat2
EA201500931A1 (ru) Производные пиридин-4-ила
SV2018005760A (es) Derivados de aminotiazol utiles como agentes antiviricos
PH12015501933B1 (en) Novel pyridine derivatives
BR112017013498B8 (pt) Formulação agrícola, seu método de preparação, e composição agrícola aquosa
UA116654C2 (uk) Похідні пурину як агоністи канабіноїдного рецептора св2
CR20160016A (es) Pirazolpiridinas sustituidas
MX2016001138A (es) Compuestos de benzoxaborol triciclico, metodo de preparacion y uso del mismo.
BR112017002852A2 (pt) compostos de azetidiniloxifenilpirrolidina
TN2015000542A1 (en) Novel compounds for the treatment of cancer
BR112015031820A2 (pt) composto, composição farmacêutica, intermediário, processo para a preparação de um composto e métodos
IN2015DN00085A (pt)
MX2016009667A (es) Forma cristalina alfa del compuesto a monobenzoato y método de preparación de la misma y composición farmacéutica que comprende la misma.
TR201819652T4 (tr) Hidrojenlenmiş bir şekerin iç dehidrasyonuna yönelik en az bir ürünü içeren bir bileşimin stabilizasyon prosesi, elde edilen bileşim ve bunun kullanımları.
MX2015016766A (es) Nuevos derivados de tetrazolona.
MX2015016603A (es) Composiciones de corticosteroides.
EA201591449A1 (ru) Способы получения противораковых композиций
EA201492280A1 (ru) Стабильный состав пексиганана
EA201501177A1 (ru) Фармацевтические композиции

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B06A Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B11D Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time
B350 Update of information on the portal [chapter 15.35 patent gazette]